Bee venom phospholipase A2, a novel Foxp3+ regulatory T cell inducer, protects dopaminergic neurons by modulating neuroinflammatory responses in a mouse model of Parkinson's disease

Journal of Immunology

Volumn 195, Issue 10, 2015, Pages 4853-4860

  Chung, Eun Sook ^a   Lee, Gihyun ^a   Lee, Chanju ^a   Ye, Minsook ^a   Chung, Hwan Suck ^a   Kim, Hyunseong ^a   Bae, Sung Joo S ^b   Hwang, Deok Sang ^a   Bae, Hyunsu ^a  

^a Kyung Hee University   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BEE VENOM; CELL SURFACE RECEPTOR; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; INSECT PROTEIN; LECTIN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR; NEUROPROTECTIVE AGENT; PHOSPHOLIPASE A2; PROSTAGLANDIN E2;

ANIMAL; DISEASE MODEL; DOPAMINERGIC NERVE CELL; GENETICS; IMMUNOLOGY; MICROGLIA; MOUSE; MPTP POISONING; PATHOLOGY; REGULATORY T LYMPHOCYTE; TRANSGENIC MOUSE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BEE VENOMS; DINOPROSTONE; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; FORKHEAD TRANSCRIPTION FACTORS; INSECT PROTEINS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MICE; MICE, TRANSGENIC; MICROGLIA; MPTP POISONING; NEUROPROTECTIVE AGENTS; PHOSPHOLIPASES A2; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES, REGULATORY;

EID: 84946603009     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500386     Document Type: Article

References (52)

1. Castro, H. J., J. I. Mendez-Lnocencio, B. Omidvar, J. Omidvar, J. Santilli, H. S. Nielsen, Jr., A. P. Pavot, J. R. Richert, and J. A. Bellanti. 2005. A phase I study of the safety of honeybee venom extract as a possible treatment for patients with progressive forms of multiple sclerosis. Allergy Asthma Proc. 26: 470-476.
2. Lee, J. D., H. J. Park, Y. Chae, and S. Lim. 2005. An overview of bee venom acupuncture in the treatment of arthritis. Evid. Based Complement. Alternat. Med. 2: 79-84.
3. Liu, X. D., J. L. Zhang, H. G. Zheng, F. Y. Liu, and Y. Chen. 2008. [Clinical randomized study of bee-sting therapy for rheumatoid arthritis]. Zhen Ci Yan Jiu 33: 197-200.
4. Walker, E. W. 1908. Bees' stings and rheumatism. BMJ 2: 1056-1060.
5. Maberly, F. H. 1910. Brief notes in the treatment of rheumatism by bee stings. Lancet 2: 235.
6. Billingham, M. E., J. Morley, J. M. Hanson, R. A. Shipolini, and C. A. Vernon. 1973. Letter: An anti-inflammatory peptide from bee venom. Nature 245: 163-164.
7. Orlov, B. N., and E. B. Romanova. 1982. [Regulatory action of bee venom on the humoral immunity system]. Nauchnye Doki. Vyss. Shkoly Biol. Nauki 1982: 41-45.
8. Hider, R. C. 1988. Honeybee venom: a rich source of pharmacologically active peptides. Endeavour 12: 60-65.
9. Hirsch, E. C., T. Breidert, E. Rousselet, S. Hunot, A. Hartmann, and P. P. Michel. 2003. The role of glial reaction and inflammation in Parkinson's disease. Ann. N. Y. Acad. Sci. 991: 214-228.
10. Kreutzberg, G. W. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19: 312-318.
11. McGeer, P. L., S. Itagaki, B. E. Boyes, and E. G. McGeer. 1988. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38: 1285-1291.
12. Block, M. L., and J. S. Hong. 2005. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 76: 77-98.
13. Appel, S. H. 2009. CD4+ T cells mediate cytotoxicity in neurodegenerative diseases. J. Clin. Invest. 119: 13-15.
14. Hunot, S., N. Dugas, B. Faucheux, A. Hartmann, M. Tardieu, P. Debré, Y. Agid, B. Dugas, and E. C. Hirsch. 1999. FcεRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-a in glial cells. J. Neurosci. 19: 3440-3447.
15. McGeer, P. L., S. Itagaki, H. Akiyama, and E. G. McGeer. 1988. Rate of cell death in parkinsonism indicates active neuropathological process. Ann. Neurol. 24: 574-576.
16. Brochard, V., B. Combadière, A. Prigent, Y. Laouar, A. Perrin, V. Beray-Berthat, O. Bonduelle, D. Alvarez-Fischer, J. Callebert, J. M. Launay, et al. 2009. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest. 119: 182-192.
17. Kurkowska-Jastrzebska, I., A. Wronska, M. Kohutnicka, A. Członkowski, and A. Członkowska. 1999. MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease. Acta Neurobiol. Exp. (Warsz.) 59: 1-8.
18. Miklossy, J., D. D. Doudet, C. Schwab, S. Yu, E. G. McGeer, and P. L. McGeer. 2006. Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys. Exp. Neurol. 197: 275-283.
19. Reynolds, A. D., D. K. Stone, J. A. Hutter, E. J. Benner, R. L. Mosley, and H. E. Gendelman. 2010. Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease. J. Immunol. 184: 2261-2271.
20. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787.
21. Liesz, A., E. Suri-Payer, C. Veltkamp, H. Doerr, C. Sommer, S. Rivest, T. Giese, and R. Veltkamp. 2009. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 15: 192-199.
22. Reynolds, A. D., R. Banerjee, J. Liu, H. E. Gendelman, and R. L. Mosley. 2007. Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease. J. Leukoc. Biol. 82: 1083-1094.
23. Chung, E. S., H. Kim, G. Lee, S. Park, H. Kim, and H. Bae. 2012. Neuroprotective effects of bee venom by suppression of neuroinflammatory responses in a mouse model of Parkinson's disease: role of regulatory T cells. Brain Behav. Immun. 26: 1322-1330.
24. Chen, W., W. Jin, N. Hardegen, K. J. Lei, L. Li, N. Marinos, G. McGrady, and S. M. Wahl. 2003. Conversion of peripheral CD4+CD252 naive T cells to CD4+ CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
25. Kopf, H., G. M. de la Rosa, O. M. Howard, and X. Chen. 2007. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. Int. Immunopharmacol. 7: 1819-1824.
26. Mucida, D., Y. Park, G. Kim, O. Turovskaya, I. Scott, M. Kronenberg, and H. Cheroutre. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
27. Baratelli, F., Y. Lin, L. Zhu, S. C. Yang, N. Heuzé-Vourc'h, G. Zeng, K. Reckamp, M. Dohadwala, S. Sharma, and S. M. Dubinett. 2005. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J. Immunol. 175: 1483-1490.
28. Broere, F., M. F. du Pré, L. A. van Berkel, J. Garssen, C. B. Schmidt-Weber, B. N. Lambrecht, R. W. Hendriks, E. E. Nieuwenhuis, G. Kraal, and J. N. Samsom. 2009. Cyclooxygenase-2 in mucosal DC mediates induction of regulatory T cells in the intestine through suppression of IL-4. Mucosal Immunol. 2: 254-264.
29. Morelli, A. E., and A. W. Thomson. 2007. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7: 610-621.
30. Mukhopadhyay, A., and P. Stahl. 1995. Bee venom phospholipase A2 is recognized by the macrophage mannose receptor. Arch. Biochem. Biophys. 324: 78-84.
31. Harris, N., M. Super, M. Rits, G. Chang, and R. A. Ezekowitz. 1992. Characterization of the murine macrophage mannose receptor: demonstration that the downregulation of receptor expression mediated by interferon-g occurs at the level of transcription. Blood 80: 2363-2373.
32. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182: 389-400.
33. Chieppa, M., G. Bianchi, A. Doni, A. Del Prete, M. Sironi, G. Laskarin, P. Monti, L. Piemonti, A. Biondi, A. Mantovani, et al. 2003. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an antiinflammatory immunosuppressive program. J. Immunol. 171: 4552-4560.
34. Garg, A., P. F. Barnes, S. Roy, M. F. Quiroga, S. Wu, V. E. García, S. R. Krutzik, S. E. Weis, and R. Vankayalapati. 2008. Mannose-capped lipoarabinomannanand prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur. J. Immunol. 38: 459-469.
35. Palm, N. W., R. K. Rosenstein, S. Yu, D. D. Schenten, E. Florsheim, and R. Medzhitov. 2013. Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. Immunity 39: 976-985.
36. Kurosaki, R., Y. Muramatsu, H. Kato, and T. Araki. 2004. Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease. Pharmacol. Biochem. Behav. 78: 143-153.
37. West, M. J., L. Slomianka, and H. J. Gundersen. 1991. Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231: 482-497.
38. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
39. Sugimoto, Y., and S. Narumiya. 2007. Prostaglandin E receptors. J. Biol. Chem. 282: 11613-11617.
40. González-Scarano, F., and G. Baltuch. 1999. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22: 219-240.
41. Matyszak, M. K. 1998. Inflammation in the CNS: balance between immunological privilege and immune responses. Prog. Neurobiol. 56: 19-35.
42. Członkowska, A., M. Kohutnicka, I. Kurkowska-Jastrzebska, and A. Członkowski. 1996. Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model. Neurodegeneration 5: 137-143.
43. Kohutnicka, M., E. Lewandowska, I. Kurkowska-Jastrzebska, A. Członkowski, and A. Członkowska. 1998. Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology 39: 167-180.
44. Kim, J. I., E. J. Yang, M. S. Lee, Y. S. Kim, Y. Huh, I. H. Cho, S. Kang, and H. K. Koh. 2011. Bee venom reduces neuroinflammation in the MPTP-induced model of Parkinson's disease. Int. J. Neurosci. 121: 209-217.
45. Yang, E. J., J. H. Jiang, S. M. Lee, S. C. Yang, H. S. Hwang, M. S. Lee, and S. M. Choi. 2010. Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models. J. Neuroinflammation 7: 69.
46. Kwon, Y. B., H. J. Lee, H. J. Han, W. C. Mar, S. K. Kang, O. B. Yoon, A. J. Beitz, and J. H. Lee. 2002. The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci. 71: 191-204.
47. Eiseman, J. L., J. von Bredow, and A. P. Alvares. 1982. Effect of honeybee (Apis mellifera) venom on the course of adjuvant-induced arthritis and depression of drug metabolism in the rat. Biochem. Pharmacol. 31: 1139-1146.
48. Benner, E. J., R. Banerjee, A. D. Reynolds, S. Sherman, V. M. Pisarev, V. Tsiperson, C. Nemachek, P. Ciborowski, S. Przedborski, R. L. Mosley, and H. E. Gendelman. 2008. Nitrated a-synuclein immunity accelerates degeneration of nigral dopaminergic neurons. PLoS One 3: e1376.
49. Sharma, S., S. C. Yang, L. Zhu, K. Reckamp, B. Gardner, F. Baratelli, M. Huang, R. K. Batra, and S. M. Dubinett. 2005. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. Cancer Res. 65: 5211-5220.
50. von Allmen, C. E., N. Schmitz, M. Bauer, H. J. Hinton, M. O. Kurrer, R. B. Buser, M. Gwerder, S. Muntwiler, T. Sparwasser, R. R. Beerli, andM. F. Bachmann. 2009. Secretory phospholipase A2-IID is an effector molecule of CD4+CD25+ regulatory T cells. Proc. Natl. Acad. Sci. USA 106: 11673-11678.
51. Marichal, T., P. Starkl, L. L. Reber, J. Kalesnikoff, H. C. Oettgen, M. Tsai, M. Metz, and S. J. Galli. 2013. A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity 39: 963-975.
52. Kalinski, P., C. M. Hilkens, A. Snijders, F. G. Snijdewint, and M. L. Kapsenberg. 1997. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159: 28-35.